Helios
- 0 Review(s)
- Add your review
The HELIOS III is a Q-Switched Nd:YAG laser with dual wavelengths at 1064nm & 532nm, efficaciously capable to treat a wide range of treatment indications. 5 different modes of operation are available for users to maximize customized treatment mapping. HELIOS III is the most technologically advanced Q-Switched Nd:YAG laser available on the market which provides outstanding treatment results.
Want to hear more about this product?
Price
Description
Technology
Advantageous Stability
HELIOS III has been intensively tested for its durability and stability in-house before its release to ensure long-lasting capabilities due to its common treatment indications. The system can be safely used over extended periods of time with no beam distortion or loss of energy and is the most reliable Q-Switch Nd:YAG available to physicians.
The system is equipped with LASEROPTEK’s proprietary thermal lens compensator which allows a single laser to be emitted from multiple incoming lasers originating from different directions to pass through it. The thermal lens compensator prevents the production of thermal buildup and loss of energy output from occurring resulting in short and long-term stable laser energy output.
The advanced stability of the HELIOS III reflects positive clinical results due to its highly uniform beam profile and additionally, the occurrence of undesirable side effects are significantly reduced.
RTP (Real Twin Pulse) Mode
A unique core technology invented and developed in-house, Real Twin Pulse or RTP allows the same energy and interval between the first and second laser pulses emitted by Q-Switched lasers. It is used to produce milder thermal damage in the targeted area and can be used to generate deeper penetration in comparison to a single pulse. HELIOS III’s RTP mode generates a maximum of 2 Joules in output energy.
Advantages
Customized Treatment Options
Capable of treating a wide array of treatment indications with the combination of dual wavelengths 1064nm and 532nm including five different modes to choose from, physicians have an extensive range of treatment settings to customize treatments. This approach completely covers the entire melanin and oxyhemoglobin absorption spectrum.
Specialized for Epidermal Lesions
The HELIOS III’s fractional 532nm Handpiece divides the origin beam into an 81 microbeam array with equal and uniform output over the projected area. This advanced technology allows higher fluence levels to be used in comparison to a bulk beam handpiece making it attractive to treating a wide variety of epidermal lesions.
This technological application lowers the risk of reactive hyper and hypo pigmentations and epidermal damage from occurring. Additionally, it is highly effective, when targeting red-colored inks for tattoo removal.
